New prognostic factors in resectable non-small cell lung cancer.
Open Access
- 1 June 1996
- Vol. 51 (6) , 638-646
- https://doi.org/10.1136/thx.51.6.638
Abstract
No abstract availableThis publication has 84 references indexed in Scilit:
- How loops, β sheets, and α helices help us to understand p53Cell, 1994
- Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-upBritish Journal of Cancer, 1994
- C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.Journal of Clinical Investigation, 1994
- bcl-2 Protein in Non-Small-Cell Lung CarcinomaNew England Journal of Medicine, 1993
- Relationship between tumor dna ploidy and regional lymph node changes in lung cancerCancer, 1992
- Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Expression of Blood-Group Antigen A — A Favorable Prognostic Factor in Non-Small-Cell Lung CancerNew England Journal of Medicine, 1991
- A specific cell surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor cell metastasisBiochemistry, 1991
- The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage 1 resected squamous cell lung cancer and long-term follow upCancer, 1989
- Flow cytometric analysis of DNA ploidy level in paraffin-embedded tissue of non-small-cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1988